Sutro Biopharma (STRO) — Free Cash Flow Generation Index
Sutro Biopharma (STRO) has a Free Cash Flow Generation Index of 0.92x as of June 2024. Free cash flow of $8.70 Million represents 1% of operating cash flow ($9.46 Million). Explore STRO capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sutro Biopharma Free Cash Flow Generation Index (2018–2022)
Historical FCF Generation Index trend for Sutro Biopharma across 2 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Sutro Biopharma.
Annual Free Cash Flow Generation for Sutro Biopharma (2018–2022)
Year-by-year Free Cash Flow Generation Index for Sutro Biopharma. Check STRO capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2022 | -1.21x | $-4.31 Million | $3.55 Million | $7.86 Million | ▼ -238.4% |
| 2018 | 0.88x | $11.13 Million | $12.68 Million | $1.56 Million | — |